Stock-Option Compensation to Drive Medium- to Long-Term Earnings Growth and Higher Corporate Value
First written in FY2023. 3 of 4 entries say "Advanced", first in FY2024. Latest entry: FY2026-H1.
106 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Number of stock acquisition rights (units)* 6,600 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common stock 660,000 Amount payable upon exercise of the stock acquisition rights (¥)* 67 (Note 2) Exercise period for the stock acquisition rights* From 24 December 2027 to 25 December 2034」
The company disclosed the details of the stock options approved on 22 December 2025: 6,600 stock acquisition rights, 660,000 common shares, an exercise price of ¥67, and an exercise period from 24 December 2027 to 25 December 2034. - FY2025AdvancedAnnual report
「In the consolidated fiscal year under review (fiscal year ended September 2025), 699,000 shares vested and 699,000 shares remained unexercised.」
The 699,000 shares under the stock options approved on 31 July 2023 vested and remained unexercised at the end of the period. After the filing date, the company also resolved the issuance of 6,600 stock acquisition rights covering 660,000 common shares, with an exercise period from 24 December 2027 to 25 December 2034. - FY2024AdvancedAnnual report
「At a meeting of the Board of Directors held on 22 November 2024, the company resolved to submit to its 22nd annual general meeting of shareholders a proposal seeking approval to delegate to the Board of Directors the authority to determine the offering terms for stock acquisition rights to be issued as stock options. Under the proposal, annual compensation of up to ¥100 million, separate from ordinary fixed regular compensation, would be provided to directors other than those serving as Audit and Supervisory Committee members, and annual compensation of up to ¥22.5 million, also separate from ordinary fixed regular compensation, would be provided to directors serving as Audit and Supervisory Committee members. The stock acquisition rights would also be issued to the company's employees and the directors and employees of affiliated companies, including sister companies. The proposal was approved as originally proposed at the annual general meeting held on 25 December 2024.」
Regarding stock option compensation, a proposal to delegate authority to issue stock acquisition rights to directors, Audit and Supervisory Committee members, employees and officers and employees of affiliated companies was approved by the shareholders after a resolution by the Board of Directors. Annual limits for directors and Audit and Supervisory Committee members were also disclosed. - FY2023First statedAnnual report
「To strengthen the link between compensation for our directors, directors serving as Audit and Supervisory Committee members, employees and directors and employees of affiliated companies and our performance and share price, and to heighten their motivation to deliver sustained improvement in performance and growth in corporate value over the medium to long term by sharing with shareholders not only the benefits of a rising share price but also the risks of a decline, the number of stock acquisition rights described below will be capped at 8,500. The maximum number of shares deliverable upon exercise will be 850,000 common shares, and the exercise period will run from the date 2 years after the resolution approving the issue through the date 10 years after that resolution.」
The company introduced a stock-option scheme for directors, Audit and Supervisory Committee members, employees and officers and employees of affiliated companies, designed to align incentives with performance and the share price and promote medium- to long-term growth in performance and corporate value. The limits are 8,500 stock acquisition rights and 850,000 common shares, with an exercise period from 2 to 10 years after the issue resolution.